Results 11 to 20 of about 13,266 (251)

Oral PUVA Versus Bath PUVA in Chronic Plaque Psoriasis: A Comparative Study of Efficacy [PDF]

open access: yesRevista da Sociedade Portuguesa de Dermatologia e Venereologia, 2018
Introduction: Phototherapy has long been recognized as beneficial for psoriasis treatment, with a favorable risk- -benefit relation. Photochemotherapy comprises the use of psoralen, either orally (oral PUVA) or topically (bath PUVA), prior to UVA ...
Katarina Kieselova   +2 more
doaj   +2 more sources

Efficacy of bath psoralen plus ultraviolet A (PUVA) vs. system PUVA in psoriasis: a prospective, open, randomized, multicentre study

open access: yesBritish Journal of Dermatology, 2013
BACKGROUND: Plaque psoriasis is an inflammatory disease affecting approximately 2% of the population. The clinical hallmarks of psoriasis are sharply demarcated, erythematous plaques with thick scales. Photochemotherapy (psoralen plus ultraviolet A, PUVA)
M. Berneburg   +10 more
semanticscholar   +3 more sources

Photochemotherapy (PUVA): An Overview

open access: yesJournal of Indian Academy of Oral Medicine and Radiology, 2010
Photochemotherapy (PUVA) has become a useful alternative in dermatologic therapy. Start from historical date up to modern era the safe and useful modes of PUVA has been documented in many immunological disorder.
Fakir Mohan Debta   +3 more
doaj   +1 more source

Phototherapy

open access: yesTurkderm Turkish Archives of Dermatology and Venereology, 2022
Considering its effects, side effects, and contraindications, phototherapy is a treatment option that can be used in patients who do not respond to topical treatments, suffer side effects, or have diffuse lesions.
Melih Akyol
doaj   +1 more source

Improvement in making methods of PUVA-treated dendritic cells [PDF]

open access: yes, 2020
PUVA処理(Psoralen+UVA照射2J)した樹状細胞(PUVA-DC)がin vitroにおいて、制御性樹状細胞の性質を獲得したことを報告してきた.その細胞をマウスGVHDモデルにて検討を行ったが、GVHD抑制作用が得られなかったため、PUVA-DCの作製条件の検討を行った。UVA照射の設定(0-2 J)を探索したが、0.2-1Jでは免疫寛容を有していなかった。次にカスパーゼ阻害剤による処理を追加したが、PUVA-DCの24時間後の生存率は改善せず免疫寛容誘導能も有していなかった.PUVA ...
Maeba, Hideaki   +3 more
core   +1 more source

Bath Psoralen Plus UVA Therapy Suppresses Keratinocyte-Derived Chemokines in Pathogenetically Relevant Cells

open access: yesJID Innovations, 2021
Psoriasis is a chronic inflammatory proliferative skin disease involving various types of chemokines regulating immune cell migration, localization, and activation. Bath psoralen plus UVA (PUVA) treatment is an established phototherapy for psoriasis, but
Yoshifumi Kanayama   +3 more
doaj   +1 more source

Phototherapy combined with systemic agents for mycosis fungoides [PDF]

open access: yesVestnik Dermatologii i Venerologii, 2023
The choice of tactics for managing a patient with mycosis fungoides is determined by the stage of the disease. In the early stages of mycosis fungoides, a treatment approach using external therapy and various ultraviolet irradiation spectra (UVB-311 nm ...
Anastasiia A. Vorontsova   +1 more
doaj   +1 more source

Management of advanced mycosis fungoides and Sézary Syndrome: International Recommendations for systemic treatments and allogeneic hematopoietic cell transplantation from the European Hematology Association, the EORTC Cutaneous Lymphoma Tumours Group, the International Society for Cutaneous Lymphoma, and the Lymphoma Working Party of the EBMT. [PDF]

open access: yesHemasphere
Abstract Advanced mycosis fungoides (MF) and Sézary syndrome (SS) are the most aggressive forms of cutaneous T‐cell lymphoma and remain associated with a poor prognosis and heterogeneous therapeutic approaches. Recent advances, including targeted therapies and improved transplant strategies, have substantially expanded treatment options, highlighting ...
Onida F   +29 more
europepmc   +2 more sources

Comparative Effectiveness and Safety of Methotrexate Versus PUVA in Severe Chronic Stable Plaque Psoriasis

open access: yesIndian Journal of Dermatology, 2021
Background: Psoriasis is a chronic, inflammatory, immune-mediated, debilitating skin disease affecting approximately 2%–3% of the global population.
Saikat Banerjee   +3 more
doaj   +1 more source

Khellin UV-A vs. psoralen UV-A: a comparative study on safety and effectiveness in vitiligo treatment [PDF]

open access: yesRomanian Medical Journal
Background. Vitiligo is a chronic depigmenting disorder with variable therapeutic outcomes. PUVA is a well-established treatment, whereas KUVA has been reported in only a few small studies, and its comparative efficacy and safety remain insufficiently ...
Ahmed Mohammed Radhi, Khalil Al-Hamdi
doaj   +1 more source

Home - About - Disclaimer - Privacy